EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:754906 - afuresertib
| Formula | C18H17Cl2FN4OS |
| Net Charge | 0 |
| Average Mass | 427.332 |
| Monoisotopic Mass | 426.04842 |
| SMILES | [H][C@@](CN)(Cc1cccc(F)c1)NC(=O)c1cc(-c2c(Cl)cnn2C)c(Cl)s1 |
| InChI | InChI=1S/C18H17Cl2FN4OS/c1-25-16(14(19)9-23-25)13-7-15(27-17(13)20)18(26)24-12(8-22)6-10-3-2-4-11(21)5-10/h2-5,7,9,12H,6,8,22H2,1H3,(H,24,26)/t12-/m0/s1 |
| InChIKey | AFJRDFWMXUECEW-LBPRGKRZSA-N |
| Roles Classification |
|---|
| Chemical Roles: | Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). Bronsted base A molecular entity capable of accepting a hydron from a donor (Brønsted acid). |
| Applications: | antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. central nervous system stimulant Any drug that enhances the activity of the central nervous system. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| afuresertib (CHEBI:754906) has role antineoplastic agent (CHEBI:35610) |
| afuresertib (CHEBI:754906) is a amphetamines (CHEBI:35338) |
| INN | Source |
|---|---|
| afuresertib | WHO MedNet |
| Synonyms | Source |
|---|---|
| ASB-183 | ChEMBL |
| ASB183 | ChEMBL |
| GSK-2110183 | ChEMBL |
| GSK2110183 | ChEMBL |
| GSK-2110183C | ChEMBL |
| GSK2110183C | ChEMBL |
| Citations |
|---|